Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded
| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| -1.41% | -5.92% | +39.12% | +141.66% | 992B | |
| -2.40% | -4.44% | +51.10% | +38.76% | 564B | |
| -2.22% | -3.78% | +16.59% | +56.92% | 391B | |
| -2.90% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.40% | -3.17% | +24.65% | +12.90% | 280B | |
| -2.45% | -2.88% | +24.29% | +29.93% | 279B | |
| -1.91% | -0.87% | -41.95% | -48.26% | 196B | |
| -1.65% | -5.18% | +15.92% | +46.87% | 184B | |
| -2.10% | -2.50% | +13.63% | +57.93% | 156B | |
| Average | -7.04% | +0.41% | +18.67% | +39.25% | 374.58B | |
| Weighted average by Cap. | -2.11% | -0.49% | +27.51% | +62.35% |
Employees
4
Sector
Pharmaceuticals
